Literature DB >> 11941947

How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value.

Philipp Dutkowski1, Gerhard Hommel, Thomas Böttger, Tilmann Schlick, Theo Junginger.   

Abstract

BACKGROUND/AIMS: The UICC recommends a number of at least six lymph nodes to be examined in the surgical therapy of esophageal cancer for a reliable pN classification. The aim of this study was to evaluate this threshold by means of the data from our patients.
METHODOLOGY: Following curative resection (R0) of esophageal cancer the numbers of examined tumor-free and tumor-involved lymph nodes were compared. Different statistical models of logistic regression were fitted to the data and checked for plausibility (Hosmer Lemeshow test). The sensitivity of a correct pN classification was then calculated and correlated to the total number of examined lymph nodes.
RESULTS: A maximum increase of the sensitivity in classifying pN occurred from 0 to 6 examined lymph nodes. Nevertheless an additional improvement of sensitivity was continuously shown up to 100 examined nodes. An over 90% sensitivity of a correct lymph node classification was reached when more than twelve nodes were examined. Thus the results demonstrate in the case of esophageal cancer, that the suggestion by the UICC to examine at least 6 nodes for defining pN appears too low and may not represent the clinical situation. A ninety percent confidence level of a correct lymph node classification can be expected above 12 examined nodes similarly to the current recommended threshold in colorectal carcinoma.
CONCLUSIONS: We suggest a new threshold for the number of examined lymph nodes of at least 12 instead of 6 nodes for accurately defining the pN category in esophageal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 11941947

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  19 in total

1.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

2.  Perioperative outcomes after transition from conventional to minimally invasive Ivor-Lewis esophagectomy in a specialized center.

Authors:  Ahmed H Hamouda; Matthew J Forshaw; Kostas Tsigritis; Greg E Jones; Aliya S Noorani; Ash Rohatgi; Abraham J Botha
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

3.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

4.  Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.

Authors:  Thomas W Rice; Hemant Ishwaran; Wayne L Hofstetter; Paul H Schipper; Kenneth A Kesler; Simon Law; E M R Lerut; Chadrick E Denlinger; Jarmo A Salo; Walter J Scott; Thomas J Watson; Mark S Allen; Long-Qi Chen; Valerie W Rusch; Robert J Cerfolio; James D Luketich; Andre Duranceau; Gail E Darling; Manuel Pera; Carolyn Apperson-Hansen; Eugene H Blackstone
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

5.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

6.  A model based on endoscopic morphology of submucosal esophageal squamous cell carcinoma for determining risk of metastasis on lymph nodes.

Authors:  Lingdun Zhuge; Shengfei Wang; Juntao Xie; Binhao Huang; Difan Zheng; Shanbo Zheng; Hengyu Mao; Arjun Pennathur; Manuel Villa Sanchez; James D Luketich; Jiaqing Xiang; Haiquan Chen; Jie Zhang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

7.  Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

8.  Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management.

Authors:  Dimitrios Fotis; Michael Doukas; Bas Pl Wijnhoven; Paul Didden; Katharina Biermann; Marco J Bruno; Arjun D Koch
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

Review 9.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27

10.  Prognostic significance of preoperative lymph node assessment for patients with stage pN0 esophageal squamous cell carcinoma after esophagectomy.

Authors:  Yan Shi; Jinming Xu; Ying Wang; Jie Tang; Chong Zhang; Wang Lv; Jian Hu
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.